Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -378,284 | -204,969 | -2,106,372 | -1,933,294 | -1,263,163 |
| Depreciation Amortization | 36,610 | 18,958 | 42,552 | 26,885 | 18,972 |
| Income taxes - deferred | N/A | N/A | -14,609 | N/A | N/A |
| Accounts receivable | 15,397 | -526 | 55,024 | 20,521 | -38,598 |
| Accounts payable and accrued liabilities | N/A | 19,080 | -10,844 | N/A | 10,650 |
| Other Working Capital | -10,394 | 1,488 | -37,006 | -29,047 | -70,644 |
| Other Operating Activity | 172,553 | 75,384 | 1,819,057 | 1,767,268 | 1,223,477 |
| Operating Cash Flow | $-164,118 | $-90,585 | $-252,198 | $-147,667 | $-119,306 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30,048 | -19,441 | -52,271 | -26,516 | -13,076 |
| Net Acquisitions | N/A | N/A | 74,728 | N/A | 1,440 |
| Purchase Of Investment | N/A | N/A | -3,691 | -13,691 | -10,191 |
| Other Investing Activity | -590 | 27 | -86,160 | -56,927 | -28,821 |
| Investing Cash Flow | $-30,638 | $-19,414 | $-67,394 | $-97,134 | $-50,648 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -648 | -322 | -1,237 | -912 | -609 |
| Common Stock Issued | 24 | 12 | 99,543 | N/A | N/A |
| Other Financing Activity | -1,645 | -578 | -2,969 | -1,514 | -1,426 |
| Financing Cash Flow | $-2,269 | $-888 | $95,337 | $-2,426 | $-2,035 |
| Exchange Rate Effect | -495 | -26 | 908 | -191 | -104 |
| Beginning Cash Position | 1,369,581 | 1,369,581 | 1,592,928 | 1,592,928 | 1,550,004 |
| End Cash Position | 1,172,061 | 1,258,668 | 1,369,581 | 1,345,510 | 1,420,835 |
| Net Cash Flow | $-197,520 | $-110,913 | $-223,347 | $-247,418 | $-129,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -164,118 | -90,585 | -252,198 | -147,667 | -119,306 |
| Capital Expenditure | -32,974 | -19,441 | -52,271 | -26,626 | -13,153 |
| Free Cash Flow | -197,092 | -110,026 | -304,469 | -174,293 | -132,459 |